EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GCKR Polymorphisms Increase the Risks of Low Bone Mineral Density in Young and Non‐Obese Patients With MASLD and Hyperuricemia

Tzu-Hao Li, Yu-Shin Huang, Chia-Chen Ma, Shin-Yu Tsai, Hung-Cheng Tsai, Hsiao-Yun Yeh, Hsiao-Chin Shen, Shiao-Ya Hong, Chien-Wei Su, Hwai-I Yang, Ying-Ying Yang iD, Ming-Chih Hou

The Kaohsiung Journal of Medical Sciences · 2025

DOI: 10.1002/kjm2.70017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2025. Verfasst von Tzu-Hao Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, Hyperuricemia, Bone Density, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taipei Veterans General Hospital, Ministry of Science and Technology, Taiwan, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic‐associated steatotic liver disease (MASLD) encompasses common comorbidities including low bone mineral density (BMD) and hyperuricemia (HU), yet relevant genetic analyses are limited. This study aimed to investigate the genetic effects of risk single nucleotide polymorphisms (SNPs) on the occurrence of low BMD in patients with MASLD and HU, particularly focusing on relatively young or non‐obese populations. We conducted a cross‐sectional study utilizing data from the Taiwan Biobank, screening a total of 150,709 participants who were prospectively enrolled over a period of 13 years. The risk SNPs for MASLD were identified. Genotype analyses of HU and its effects on the occurrence of low BMD in the general population were evaluated, with further analyses of common SNPs focusing on patients with MASLD, including subgroup analyses on relatively young and non‐obese populations. A total of 20,496 participants were eligible for analysis, including 7526 patients with MASLD. Several risk SNPs for MASLD were identified. Furthermore, MASLD patients carrying the PNPLA3‐rs738409 C_C, PNPLA3‐rs2896019 T_T, GCKR‐rs780094 T_T, and GCKR‐rs1260326 T_T genotypes exhibited an increased risk of comorbidity with HU. Trend analysis revealed that the T alleles in GCKR‐rs780094 and GCKR‐rs1260326 were associated with the occurrence of low BMD in MASLD individuals comorbid with HU, particularly among relatively young or non‐obese populations. In relatively young, non‐obese patients with MASLD and HU, genetic effects significantly increase the risk of occurrence of low BMD. Given the presence of genetic effects in these ostensibly low‐risk groups, heightened awareness and close follow‐up are recommended.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymorphism, Single NucleotideHyperuricemiaBone DensityAdaptor Proteins, Signal TransducingNon-alcoholic Fatty Liver DiseaseHumansMaleFemaleMiddle AgedAdultGenetic Predisposition to DiseaseCross-Sectional StudiesMembrane ProteinsTaiwanRisk FactorsLipaseGenotypeAgedAcyltransferasesPhospholipases A2, Calcium-Independent

Stichwörter der Autor:innen

hyperuricemialow bone mineral densitymetabolic‐associated steatotic liver diseasesingle nucleotide polymorphisms

Substanzen

GCKR protein, humanAdaptor Proteins, Signal TransducingMembrane ProteinsPNPLA3 protein, humanLipaseAcyltransferasesPhospholipases A2, Calcium-Independent

Autor:innen und Institutionen

  • Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
  • Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
  • Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taipei Veteran General Hospital, Taipei, Taiwan.

ORCID-Profile: Ying-Ying Yang

Förderung

  • Taipei Veterans General Hospital
  • Ministry of Science and Technology, Taiwan
  • National Science and Technology Council

Zitieren

APA

Li, T. H., Huang, Y. S., Ma, C. C., Tsai, S. Y., Tsai, H. C., Yeh, H. Y., Shen, H. C., Hong, S. Y., Su, C. W., Yang, H. I., Yang, Y. Y., & Hou, M. C. (2025). GCKR Polymorphisms Increase the Risks of Low Bone Mineral Density in Young and Non‐Obese Patients With MASLD and Hyperuricemia. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70017

Vancouver

Li TH, Huang YS, Ma CC, Tsai SY, Tsai HC, Yeh HY, et al. GCKR Polymorphisms Increase the Risks of Low Bone Mineral Density in Young and Non‐Obese Patients With MASLD and Hyperuricemia. The Kaohsiung Journal of Medical Sciences. 2025. doi:10.1002/kjm2.70017

BibTeX
@article{Li2025,
  author = {Li, Tzu-Hao and Huang, Yu-Shin and Ma, Chia-Chen and Tsai, Shin-Yu and Tsai, Hung-Cheng and Yeh, Hsiao-Yun and Shen, Hsiao-Chin and Hong, Shiao-Ya and Su, Chien-Wei and Yang, Hwai-I and Yang, Ying-Ying and Hou, Ming-Chih},
  title = {GCKR Polymorphisms Increase the Risks of Low Bone Mineral Density in Young and Non‐Obese Patients With MASLD and Hyperuricemia},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2025},
  doi = {10.1002/kjm2.70017}
}
Kostenlos starten →